Papa Medical, which sells branded cannabis vape devices primarily in North American and Europe, announced terms for its IPO on Friday.
The City of Industry, CA-based company plans to raise $5 million by offering 1.3 million shares at $4. At the proposed price, Papa Medical would command a market value of $85 million.
Papa Medical sells cannabis e-vapor products under the Cannapresso brand. As of September 30, 2024, the company has launched approximately 50 series of e-vapors. It sells its products in North America and Europe, as well as the UAE and elsewhere.
Papa Medical was founded in 2018 and booked $47 million in sales for the 12 months ended March 31, 2025. It plans to list on the Nasdaq under the symbol PAPA. Tiger Brokers and TFI Securities are the joint bookrunners on the deal.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。